Coelho Philip H's Form 4 filing
Catalyst Pharmaceuticals, Inc. (CPRX) · filed Nov 23, 2022
- Accession no.
- 0001161697-22-000560
- Filed
- Nov 23, 2022
- Trade date
- Nov 21-23, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.59M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Coelho Philip HCIK 0001109775 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 21, 2022 | Common stock, par value $0.001 per share | SSaleDisposed | −70,000 | $15.23 | −$1,066,100 | 179,553 | Direct | |
| Nov 22, 2022 | Common stock, par value $0.001 per share | SSaleDisposed | −20,001 | $17.30 | −$346,017.3 | 159,552 | Direct | |
| Nov 23, 2022 | Common stock, par value $0.001 per share | SSaleDisposed | −9,999 | $17.45 | −$174,482.55 | 149,553 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.